Trials / Completed
CompletedNCT01386944
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
Non Interventional Observational Study to Collect Data for the Effect of Switching to Neupro® on Severity of Restless Leg Syndrome (RLS) Symptoms and Augmentation as Well as the Change in Treatment Regimen Used, in RLS Patients With Previous Augmentation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to assess the effect of Neupro® on the severity of Restless Leg Syndrome (RLS) symptoms and augmentation in patients with augmentation associated with previous oral dopaminergic therapy. In addition, the change in treatment regimen used when switching to Neupro® will be evaluated.
Conditions
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2011-07-01
- Last updated
- 2018-04-04
- Results posted
- 2014-08-15
Locations
18 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01386944. Inclusion in this directory is not an endorsement.